Memantine is classified as an NMDA receptor antagonist and is primarily used in the treatment of moderate to severe Alzheimer's disease. Alzheimer's disease is a progressive neurological disorder characterized by memory loss and cognitive decline. Memantine helps improve cognitive function and may slow the progression of symptoms by regulating glutamate activity in the brain. Its clinical relevance lies in enhancing the quality of life for Alzheimer's patients. In summary, Memantine is essential for managing cognitive symptoms in Alzheimer's disease.
Memantine selectively blocks NMDA receptors, modulating glutamate activity and preventing excitotoxicity, which contributes to neuronal damage.




